Extension of temporary measures concerning designation of psychotropic drugs eyed

Published: 2003-10-17 06:57:00

Updated: 2003-10-17 06:57:00

The Korea Food and Drug Administration announced it would extend its 60-day temporary measures concerning the recent designation of psychotropic drugs (dextromethorphan, and carisoprodol and its salt) based on the presidential Degree until the year-end from the end of September this year, in resp...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK